Extracorporeal Membrane Oxygenation in Children With Cancer or Hematopoietic Cell Transplantation: Single-Center Experience in 20 Consecutive Patients
Open Access
- 27 April 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Abstract
Extracorporeal membrane oxygenation (ECMO) is a rescue therapy for severe respiratory and/or circulatory failure. Few data exist on the potential benefit of ECMO in immunocompromised pediatric patients with cancer and/or hematopoietic cell transplantation (HCT). Over a period of 12 years, eleven (1.9%) of 572 patients with new diagnosis of leukemia/lymphoma and nine (3.5%) of 257 patients post allogeneic HCT underwent ECMO at our center. Five (45%) and two (22%) patients, respectively, survived to hospital discharge with a median event-free survival of 4.2 years. Experiences and outcomes in this cohort may aid clinicians and families when considering ECMO for individual patients.Keywords
This publication has 19 references indexed in Scilit:
- Outcomes of pediatric patients with oncologic disease or following hematopoietic stem cell transplant supported on extracorporeal membrane oxygenation: The PEDECOR experiencePediatric Blood & Cancer, 2020
- Extracorporeal Membrane Oxygenation Support in Children With Hematologic Malignancies in SwedenJournal of Pediatric Hematology/Oncology, 2020
- Extracorporeal Membrane Oxygenation Mortality in High-Risk Populations: An Analysis of the Pediatric Health Information System DatabaseASAIO Journal, 2020
- Treatment of Children With Cancer and/or Hematopoietic Stem Cell Transplantation in the Intensive Care Unit: Experience at a Large European Pediatric Cancer CenterJournal of Pediatric Hematology/Oncology, 2020
- Extracorporeal membrane oxygenation offers long-term survival in childhood leukemia and acute respiratory failureCritical Care, 2018
- Pediatric Extracorporeal Life Support Organization Registry International Report 2016ASAIO Journal, 2017
- Extracorporeal membrane oxygenation in pediatric recipients of hematopoietic stem cell transplantation: an updated analysis of the Extracorporeal Life Support Organization experienceIntensive Care Medicine, 2014
- Extracorporeal membrane oxygenation for pediatric respiratory failure: Survival and predictors of mortality*Critical Care Medicine, 2011
- Extracorporeal life support for support of children with malignancy and respiratory or cardiac failure: The extracorporeal life support experience*Critical Care Medicine, 2009
- Extracorporeal life support for severe respiratory failure in children with immune compromised conditions*Pediatric Critical Care Medicine, 2008